559 related articles for article (PubMed ID: 34921145)
21. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
22. IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway.
Guo Q; Yu DY; Yang ZF; Liu DY; Cao HQ; Liao XW
Dig Liver Dis; 2020 May; 52(5):573-581. PubMed ID: 31818638
[TBL] [Abstract][Full Text] [Related]
23. Replication Protein A 3 Is Associated with Hepatocellular Carcinoma Tumorigenesis and Poor Patient Survival.
Xiao W; Zheng J; Zhou B; Pan L
Dig Dis; 2018; 36(1):26-32. PubMed ID: 28683444
[TBL] [Abstract][Full Text] [Related]
24. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
25. LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway.
Luo Q; Wang C; Jin G; Gu D; Wang N; Song J; Jin H; Hu F; Zhang Y; Ge T; Huo X; Chu W; Shu H; Fang J; Yao M; Gu J; Cong W; Qin W
Carcinogenesis; 2015 Oct; 36(10):1201-12. PubMed ID: 26249360
[TBL] [Abstract][Full Text] [Related]
26. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
27. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma.
Tang B; Zhu J; Li J; Fan K; Gao Y; Cheng S; Kong C; Zheng L; Wu F; Weng Q; Lu C; Ji J
Cell Commun Signal; 2020 Oct; 18(1):174. PubMed ID: 33115468
[TBL] [Abstract][Full Text] [Related]
28. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.
Yang J; Zhang X; Liu L; Yang X; Qian Q; Du B
Life Sci; 2021 Jan; 264():118711. PubMed ID: 33186566
[TBL] [Abstract][Full Text] [Related]
29. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells.
Bai T; Lei P; Zhou H; Liang R; Zhu R; Wang W; Zhou L; Sun Y
J Cell Mol Med; 2019 Nov; 23(11):7349-7359. PubMed ID: 31507082
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3.
Huang Z; Zhang Y; Li H; Zhou Y; Zhang Q; Chen R; Jin T; Hu K; Li S; Wang Y; Chen W; Huang Z
Cell Death Dis; 2019 Dec; 10(12):936. PubMed ID: 31819048
[TBL] [Abstract][Full Text] [Related]
31. Ficolin 3 promotes ferroptosis in HCC by downregulating IR/SREBP axis-mediated MUFA synthesis.
Yuan Y; Xu J; Jiang Q; Yang C; Wang N; Liu X; Piao HL; Lu S; Zhang X; Han L; Liu Z; Cai J; Liu F; Chen S; Liu J
J Exp Clin Cancer Res; 2024 May; 43(1):133. PubMed ID: 38698462
[TBL] [Abstract][Full Text] [Related]
32. Increased LCN2 (lipocalin 2) in the RPE decreases autophagy and activates inflammasome-ferroptosis processes in a mouse model of dry AMD.
Gupta U; Ghosh S; Wallace CT; Shang P; Xin Y; Nair AP; Yazdankhah M; Strizhakova A; Ross MA; Liu H; Hose S; Stepicheva NA; Chowdhury O; Nemani M; Maddipatla V; Grebe R; Das M; Lathrop KL; Sahel JA; Zigler JS; Qian J; Ghosh A; Sergeev Y; Handa JT; St Croix CM; Sinha D
Autophagy; 2023 Jan; 19(1):92-111. PubMed ID: 35473441
[TBL] [Abstract][Full Text] [Related]
33. FNDC5 induces M2 macrophage polarization and promotes hepatocellular carcinoma cell growth by affecting the PPARγ/NF-κB/NLRP3 pathway.
Liu H; Wang M; Jin Z; Sun D; Zhu T; Liu X; Tan X; Shi G
Biochem Biophys Res Commun; 2021 Dec; 582():77-85. PubMed ID: 34695754
[TBL] [Abstract][Full Text] [Related]
34. RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-catenin-ferroptosis axis.
Li Z; Caron de Fromentel C; Kim W; Wang WH; Sun J; Yan B; Utturkar S; Lanman NA; Elzey BD; Yeo Y; Zhang H; Kazemian M; Levrero M; Andrisani O
Cell Death Dis; 2023 Nov; 14(11):786. PubMed ID: 38036507
[TBL] [Abstract][Full Text] [Related]
35. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
[TBL] [Abstract][Full Text] [Related]
36. EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer.
Lin SR; Wen YC; Yeh HL; Jiang KC; Chen WH; Mokgautsi N; Huang J; Chen WY; Liu YN
Oncogene; 2020 Oct; 39(44):6757-6775. PubMed ID: 32963351
[TBL] [Abstract][Full Text] [Related]
37. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma.
Li ZJ; Dai HQ; Huang XW; Feng J; Deng JH; Wang ZX; Yang XM; Liu YJ; Wu Y; Chen PH; Shi H; Wang JG; Zhou J; Lu GD
Acta Pharmacol Sin; 2021 Feb; 42(2):301-310. PubMed ID: 32699265
[TBL] [Abstract][Full Text] [Related]
38. Tiliroside targets TBK1 to induce ferroptosis and sensitize hepatocellular carcinoma to sorafenib.
Yang C; Lu T; Liu M; Yuan X; Li D; Zhang J; Zhou L; Xu M
Phytomedicine; 2023 Mar; 111():154668. PubMed ID: 36657316
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway.
Zhang W; Pan R; Lu M; Zhang Q; Lin Z; Qin Y; Wang Z; Gong S; Lin H; Chong S; Lu L; Liao W; Lu X
Oncogene; 2021 Nov; 40(45):6369-6380. PubMed ID: 34588619
[TBL] [Abstract][Full Text] [Related]
40. Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma.
Yu J; Wang N; Gong Z; Liu L; Yang S; Chen GG; Lai PBS
Oncogene; 2021 Jan; 40(3):492-507. PubMed ID: 33184472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
